| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 6e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |